Yecuris Corp, based in Portland, OR, is a leading provider of next-generation tools for hepatic research and discovery. Their FRG KO platform offers unprecedented physiological relevance, allowing researchers to save precious time in their discovery cycle. With applications in gene editing, gene therapy, infectious diseases, and more, Yecuris Corp's humanized FRG KO models enable breakthrough science and provide researchers with accurate and relevant results.
Yecuris Corp's FRG KO platform is trusted by researchers worldwide for its ability to significantly cut discovery time. Whether it's optimizing gene cell therapy, testing new drugs for metabolism and toxicology, or studying human liver diseases, Yecuris Corp's platform offers a complete solution. With over a decade of experience and a commitment to human relevance, Yecuris Corp is at the forefront of hepatic research and is dedicated to advancing scientific knowledge in the field.
Generated from the website